Literature DB >> 21562432

Quantitative assessment of changes in trabeculectomy blebs after laser suture lysis using anterior segment coherence tomography.

Chelvin C A Sng1, Mandeep Singh, Paul Tec Kuan Chew, Cheryl S Ngo, Ce Zheng, Tin A Tun, Jovina L S See, Marcus Ang, Seng Chee Loon, Tin Aung.   

Abstract

PURPOSE: To quantify changes in bleb morphology after laser suture lysis (LSL) using anterior segment optical coherence tomography (AS-OCT). PATIENTS AND METHODS: This was a prospective observational case series of patients who underwent trabeculectomy surgery with mitomycin-C and required subsequent LSL. Subjects were assessed before and immediately after LSL, and at 3 months after LSL. At each visit, a standardized cross-sectional AS-OCT image of the bleb was obtained, from which a masked observer measured bleb height (hB), cavity height (hC), wall cross sectional area (AW), cavity cross sectional area (AC), and bleb cross sectional area (AB) using custom software.
RESULTS: Twenty-five subjects (25 eyes) were examined. LSL was performed at a mean of 21.5±16.3 days after trabeculectomy. Immediately after LSL, there was a significant increase in mean hB (P=0.026) and mean hC (P=0.45) from pre-LSL. At 3 months after LSL, there was a significant increase in mean hB (P=0.003), mean AC (P=0.047), and mean AB (P=0.006) as compared with before LSL. Increase in hB and hC immediately after LSL was predictive of outcome at month 3.
CONCLUSIONS: AS-OCT was able to quantify changes in bleb morphology after LSL, some of which were predictive of eventual outcome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21562432     DOI: 10.1097/IJG.0b013e31820e2d23

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  8 in total

1.  Effect of laser suture lysis on filtration openings: a prospective three-dimensional anterior segment optical coherence tomography study.

Authors:  H-K Cho; S Kojima; T Inoue; A Fukushima; C Kee; H Tanihara
Journal:  Eye (Lond)       Date:  2015-07-24       Impact factor: 3.775

2.  Anterior Segment Optical Coherence Tomography: Applications for Clinical Care and Scientific Research.

Authors:  Jing Shan; Charles DeBoer; Benjamin Y Xu
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019-04-25

3.  Novel Automated Approach to Predict the Outcome of Laser Peripheral Iridotomy for Primary Angle Closure Suspect Eyes Using Anterior Segment Optical Coherence Tomography.

Authors:  Victor Koh; Issac Niwas Swamidoss; Maria Cecilia D Aquino; Paul T Chew; Chelvin Sng
Journal:  J Med Syst       Date:  2018-04-27       Impact factor: 4.460

4.  Intraoperative use of spectral-domain optical coherence tomography during Descemet's stripping automated endothelial keratoplasty.

Authors:  Chelvin Ca Sng; Federico Luengo Gimeno; Jodhbir S Mehta; Hla Myint Htoon; Donald T Tan
Journal:  Clin Ophthalmol       Date:  2012-03-23

Review 5.  Clinical applications of anterior segment optical coherence tomography.

Authors:  Su-Ho Lim
Journal:  J Ophthalmol       Date:  2015-03-03       Impact factor: 1.909

Review 6.  Anterior segment optical coherence tomography imaging of conjunctival filtering blebs after glaucoma surgery.

Authors:  Rodolfo Mastropasqua; Vincenzo Fasanella; Luca Agnifili; Claudia Curcio; Marco Ciancaglini; Leonardo Mastropasqua
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 7.  Confocal Microscopy and Anterior Segment Optical Coherence Tomography Imaging of the Ocular Surface and Bleb Morphology in Medically and Surgically Treated Glaucoma Patients: A Review.

Authors:  Carmela Carnevale; Ivano Riva; Gloria Roberti; Manuele Michelessi; Lucia Tanga; Alice C Verticchio Vercellin; Luca Agnifili; Gianluca Manni; Alon Harris; Luciano Quaranta; Francesco Oddone
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

8.  Optical coherence tomography angiography in dural carotid-cavernous sinus fistula.

Authors:  Marcus Ang; Chelvin Sng; Dan Milea
Journal:  BMC Ophthalmol       Date:  2016-07-07       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.